MBNL1 Antilichaam - C-terminal regio : FITC (ARP41228 T100-FITC)

Muscleblind-like splicing regulator 1

EXP, MBNL

4154

Q86UV9

NP_997179

Human, Rat

The immunogen is a synthetic peptide directed towards the C terminal region of human MBNL1

MBNL1 contains 4 C3H1-type zinc fingers and binds to CUG triplet repeat expansion dsRNA.

DAB1; AES; AEN; UBC; ABI3BP; ZNHIT3; VCAM1; ITGA4; IDH3A; FN1; TIAL1; APP; BIN1; ITSN2; DDX17; HNRNPL; HNRNPK; HNRNPH3; HNRNPH2; HNRNPH1; HNRNPF; HNRNPA2B1; DHX9; DDX5

FITC: Fluorescein Isothiocyanate

Polyclonal Antibody

WB, IHC

MBNL1 is strongly supported by BioGPS gene expression data to be expressed in Jurkat

0.5 mg/ml

Human: 100%; Rat: 83%

Liquid. Purified antibody supplied in 1x PBS buffer.

All conjugated antibodies should be stored in light-protected vials or covered with a light protecting material (i.e. aluminum foil) . Conjugated antibodies are stable for at least 12 months at 4C. If longer storage is desired (24 months), conjugates may be diluted with up to 50% glycerol and stored at -20C to -80C. Freezing and thawing conjugated antibodies will compromise enzyme activity as well as antibody binding.

37kDa

Adereth, Y., (2005) Nat. Cell Biol. 7 (12), 1140-1147

Wet Ice

340

MBNL1

MBNL1

Rabbit

Muscleblind-like protein EXP40s EMBL AAP30726.1

NM_207296

LCPQQQHLPQVFPSLQQPQPTSPILDASTLLGATSCPAAAAGKMIPIISA